EXPO (NASDAQ: EXPO) insider files Form 144 for 1,737-share sale
Rhea-AI Filing Summary
Catherine Corrigan has filed a notice of proposed sale for 1,737 shares of EXPO common stock, expected on 07/15/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares are shown as acquired that day via cash exercise of stock options. The notice also lists 10b5-1 sales of 4,119 and 4,194 EXPO shares on 06/15/2026 and 05/15/2026, with stated values of $235,303.23 and $226,725.54, respectively.
Positive
- None.
Negative
- None.
Key Figures
Proposed shares for sale: 1,737 shares
Stated value of proposed sale: $107,832.96
Recent 10b5-1 sale shares: 4,119 shares
+3 more
6 metrics
Proposed shares for sale
1,737 shares
EXPO common stock proposed for sale on 07/15/2026
Stated value of proposed sale
$107,832.96
Value associated with 1,737 EXPO common shares
Recent 10b5-1 sale shares
4,119 shares
EXPO common sold on 06/15/2026 under 10b5-1 Sales
06/15/2026 sale value
$235,303.23
Stated value for 4,119 EXPO shares sold 06/15/2026
Earlier 10b5-1 sale shares
4,194 shares
EXPO common sold on 05/15/2026 under 10b5-1 Sales
05/15/2026 sale value
$226,725.54
Stated value for 4,194 EXPO shares sold 05/15/2026
Key Terms
Form 144, 10b5-1 Sales, Exercise of Stock Options, Executive Financial Services
4 terms
Form 144 regulatory
"144: Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 Sales regulatory
"10b5-1 Sales for CATHERINE CORRIGAN 149 COMMONWEALTH DRIVE"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Exercise of Stock Options financial
"Common | 07/15/2026 | Exercise of Stock Options | Issuer"
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What recent EXPO stock sales by Catherine Corrigan are listed, and in what amounts?
Two prior EXPO common stock sales are listed as 10b5-1 Sales: 4,119 shares for $235,303.23 on 06/15/2026 and 4,194 shares for $226,725.54 on 05/15/2026, providing recent trading history over the preceding three months.
Are Catherine Corrigan’s recent EXPO stock sales associated with a Rule 10b5-1 plan?
Yes. Both past transactions are explicitly labeled “10b5-1 Sales” for Catherine Corrigan. This wording indicates they were executed under a pre-arranged Rule 10b5-1 trading plan rather than as purely discretionary open-market trades.